Please Wait a Moment
X

Articles

03Mar

CTS to Implement the Grifols Procleix Ultrio Elite Assay Beginning June 1, 2020

03 Mar, 2020 | Return|

Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ultrio Assay to the Grifols Procleix Ultrio Elite Assay on the fully automated Panther System.

Read all about it on the Communication page by clicking the this link:Communications

Related

CTS Tampa Implementation date change for Ultrio Elite

CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...

Read More >

COVID-19 Antibody Testing Frequently Asked Questions

The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...

Read More >

Confirmatory Algorithm and Assay Changes Effective September 30, 2019

On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...

Read More >

National Blood Donor Month – January 2020

That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...

Read More >

CTS to Implement Licensed Babesia testing

In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols  ...

Read More >

CTS Implements HLA Class I and II Testing on the Gemini

CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...

Read More >